Steven Sobieski

This profile gathers the share dealings of Steven Sobieski across 3 companies, led by Lifecell Corp, Roka BioScience, Inc. and Insulet Corp. Between 3 January 2006 and 6 November 2015, the trades on record add up to 75 filings.

The open-market side counts 22 purchases for €48k alongside 4 sales for €1.1M. The net balance comes to €1.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 29 share grants and 13 option exercises.

In size, the median ticket on the buying side is €93.

On 9 November 2015 came the latest disclosure, a share grant for €437 in Roka BioScience, Inc. The clock since the last published purchase (19 March 2009) now reads 6,428 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.